These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2875969)

  • 1. Synthesis and conformational study of two L-prolyl-L-leucyl-glycinamide analogues with a reduced peptide bond.
    Vander Elst P; Elseviers M; De Cock E; Van Marsenille M; Tourwé D; Van Binst G
    Int J Pept Protein Res; 1986 Jun; 27(6):633-42. PubMed ID: 2875969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Baures PW; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2349-52. PubMed ID: 10476867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
    Björkman S; Castensson S; Sievertsson H
    J Med Chem; 1979 Aug; 22(8):931-5. PubMed ID: 40028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
    Johnson RL; Rajakumar G; Yu KL; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear-magnetic-resonance study of aggregations and conformations of melanostatin and related peptides.
    Higashijima T; Tasumi M; Miyazawa T; Miyoshi M
    Eur J Biochem; 1978 Sep; 89(2):543-56. PubMed ID: 30631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of analogues of Pro-Leu-Gly-NH2 modified at the leucyl residue.
    Johnson RL; Bontems RJ; Yang KE; Mishra RK
    J Med Chem; 1990 Jun; 33(6):1828-32. PubMed ID: 1971310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational preference of Leu side chain in melanostatin in DMSO.
    Sasidhar YU; Dhingra MM; Saran A
    Indian J Biochem Biophys; 1990 Apr; 27(2):69-75. PubMed ID: 1972373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active and inactive L-prolyl-L-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's disease.
    Case TC; Snider SR; Hruby VJ; Rockway T
    Life Sci; 1985 Jul; 36(26):2531-7. PubMed ID: 2861549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.
    Björkman S; Sievertsson H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jun; 298(2):79-81. PubMed ID: 18686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids.
    Evans MC; Pradhan A; Venkatraman S; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1999 Apr; 42(8):1441-7. PubMed ID: 10212130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogues possessing cyclic amino acid residues at the C-terminal position.
    Johnson RL; Rajakumar G; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2100-4. PubMed ID: 2876103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dopa potentiating analogs of Pro-Leu-Gly-NH2 with oral efficacy.
    Albrecht HP; Hofman HP; Klebe G; Kreiskott H
    Boll Chim Farm; 1991 Feb; 130(2):55-9. PubMed ID: 1678611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN
    Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the structural requirements for dopa potentiation and oxotremorine antagonism by L-prolyl-L-leucylglycinamide.
    Johnson RL; Smissman EE; Plotnikoff NP
    J Med Chem; 1978 Feb; 21(2):165-9. PubMed ID: 23433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal-state structural analysis of two gamma-lactam-restricted analogs of Pro-Leu-Gly-NH2.
    Valle G; Crisma M; Toniolo C; Yu KL; Johnson RL
    Int J Pept Protein Res; 1989 Mar; 33(3):181-90. PubMed ID: 2565891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic MIF analogues. Part I: synthesis by four-component condensation (4 CC) and classical methods.
    Failli A; Sestanj K; Immer HU; Götz M
    Arzneimittelforschung; 1977; 27(12):2286-9. PubMed ID: 23794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of metabolism in the action of prolyl-leucyl-glycinamide on the development of tolerance to the analgesic effect of morphine.
    Bhargava HN
    Neuropharmacology; 1986 Jul; 25(7):737-41. PubMed ID: 2875417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN
    J Pharmacol Exp Ther; 1981 Aug; 218(2):404-8. PubMed ID: 6114170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.